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Abstract
Small bowel transplants are less common than other organ transplants. 
Histological criteria for rejection of the transplanted small intestine were proposed 
at the 8th International Symposium on Small Intestinal Transplantation 2003-2004. 
The Banff Conference on Transplant Disease Pathology, an international conference 
on the rejection of small bowel transplants, was held in 2019, and unifying diagnos-
tic criteria were discussed (https://banfffoundation.org/pittsburgh-2019/). These 
histological criteria are expected to be standardized in the near future. This review 
outlines new findings such as apoptosis and apoptotic-body phagocytic findings in 
the lamina propria and behavior of natural killer T (NKT) cells, in addition to pre-
viously known crypt Fas-related apoptosis in acute cellular rejection. Furthermore, 
we review the case of a recipient who has shown no rejection for 5 years after 
transplantation. In the transplanted small intestine of this patient, the lymphocytes 
were replaced by those of another male patient.
Keywords: intestinal transplantation, histology, rejection, natural killer T cells, 
apoptosis, tolerance
1. Introduction
1.1 Current status of small bowel transplantation
Small bowel transplantation (SBT) is one of the standard treatments for patients 
who are unable to consume a regular diet and have complications from the irre-
versible requirement of parenteral nutrition [1]. Hirschsprung’s disease [2, 3] and 
Crohn’s disease [4] patients are two examples. Recent effective immunosuppressive 
drugs, well-controlled postoperative care, and advances in diagnostic techniques 
have significantly improved the outcome of SBT [5]. Immunosuppressants such as 
mycophenolate mofetil, tacrolimus, and steroids, are routinely used for long-term 
management after transplantation [6, 7].
Acute cellular rejection (ACR) is a major cause of impaired colonization by the 
transplanted small intestine, and it frequently accompanies chronic and irreversible 
changes such as ulcers and lamina propria fibrosis. ACR has remained a risk factor 
that impedes functional recovery of the intestinal graft [1, 8, 9]. On the other hand, 
pathologists frequently encounter various pathologies of the intestinal allograft 
[10–12]. For example, mechanical failure of the graft due to operation during 
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surgery may occur during the early phase after transplantation. Cytomegalovirus 
(CMV) enteritis and Epstein–Barr virus -related enteritis are severe side effects 
and post-transplantation lymphoproliferative disorders/diseases [13–15]. It is often 
difficult to make a differential diagnosis of the ACR findings. However, histologic 
diagnosis is critical for the selection of immunosuppressants and their respective 
doses. Tacrolimus, cyclosporin, and steroids are commonly prescribed in the early 
stages of rejection [16]. If an excessive dose is administered, the occurrences of 
CMV enteritis and EBV enteritis become inevitable.
Among the various histological features, crypt epithelial cell apoptosis has been 
evaluated as a highly reproducible finding. However, other histological findings 
have been proposed at different institutions. We have also previously suggested 
other findings as indicators of ACR [17–19].
2. Diagnostic criteria for ACR
2.1 Crypt apoptosis
Crypt apoptosis is considered a unique feature of ACR in SBT. The crypt is 
an architectural element that is located at the base of the villous epithelium and 
serves as the source of mucosal cells. Paneth cells, stem cells, and reserve stem 
cells are included in the crypt. Enterocytes are differentiated from reserve stem 
cells in the crypt and migrate to the tips of villi through the transit amplifying 
zone [20]. The kinetics of differentiation and loss of enterocytes contribute to the 
maintenance of quick renewal for mucosal homeostasis. The supply of entero-
cytes becomes interrupted by apoptosis in the crypt, and the shortening of villi 
becomes unavoidable. When ulceration occurs, the lesion is susceptible to infec-
tious enteritis such as CMV- and EBV-related enteritis, for a significant period of 
time [21, 22].
Pathologically, the diagnosis of small bowel transplant rejection is based on 
the appearance of 6 or more apoptotic lesions per ten crypts [3, 4] (Table 1). The 
detection of crypt apoptosis is commonly used because of its high reproducibility. 
Nevertheless, discussions about the number of lesions per crypt were held at the 
Banff Conference 2019. In the case we experienced, if more than six apoptotic cells 
were detected in the crypts, subsequent ulceration is inevitable, and infection from 
the ulcer site might occur. Therefore, we considered that immunosuppressants 
should be administered when apoptotic cells were observed in the crypt [18].
Previous apoptosis findings have shown that the cells are eosinophilic with an 
intensely stained nucleus [17, 18] (Figure 1). Cells with lobulated nuclei, such as 
neutrophils and apoptotic cells, can be confused morphologically; therefore, careful 
observation is necessary. Terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) staining is one method to avoid this confusion. This staining 
procedure involves an enzyme-mediated reaction. First, the fragmented DNA is 
labeled with biotin containing terminal deoxynucleotidyl transferase. The labeled 
DNA then reacts with streptavidin for staining. Both labels with 3,3′-diaminobenzi-
dine (DAB) and fluorescein isothiocyanate (FITC) are available for visualization of 
the apoptotic body [18].
As apoptosis progresses, fragmented cell debris (apoptotic bodies) are observed 
in or around the crypt. Increasing the dose of the immunosuppressive drug sup-
presses the progression of apoptosis. Therefore, quick detection of apoptosis is 
critical for effective immunosuppression therapy [18, 19].
The factors that cause such apoptotic responses in the crypt and lamina propria 
are poorly understood. It is possible that cytotoxic T lymphocytes (CTLs) can directly 
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attack the crypt of the graft. However, it is not always histologically evident that 
CTLs directly infiltrate near the crypt and remain near this area. There is also a note-
worthy research report suggesting that CD8-positive CTLs are not always involved 
in ACR [23]. At the basic research level, rejection of the apoptosis-inducing factors 
perforin and granzyme B released from CTLs has been reported [24]. Therefore, the 
destruction of the mucosal immune system by local increases in complement and 
inflammatory cytokines is thought to be the cause of apoptosis.
2.2 Immunohistochemical monitoring
In addition to the crypt apoptosis, apoptotic lymphocytes are identified by 
systematic immunostaining of lymphocyte surface antigens: T cell surface antigens 
CD3, CD4, and CD8; B cell surface antigens CD20 and CD79a; natural killer cell 
surface antigen CD56; and activated lymphocytes Fas and its ligand (FasL) [25]. 
FasL, also known as CD95L, is a surface antigen of activated cytotoxic T cells and 
NK cells are observed at the onset of rejection [18] (Figure 2, upper panels).
Apoptotic bodies are also been observed in the lamina propria and Peyer’s patch 
(PP) distant from the crypt, and the macrophages that phagocytose them often 
aggregate to present granuloma-like findings. Notably, these bodies are stained with 
Histologic grade
Indeterminate Crypt apoptosis and 
related findings
Lymphocytic apoptosis 
in the lamina  
propria [18]
Up to 6 apoptotic 
bodies per 10 crypts
None




bodies in the lamina 
propria
Phagocytosis of 





A few apoptotic body 




Severe/exfoliative Mucosal ulceration Apoptotic bodies 
aggregate in the lamina 
propria
Granuloma consisting of 
macrophages
Table 1. 
Histological criteria for ACR of the intestinal allograft [10]. The findings under the lymphocyte and 
macrophage categories refer to our previous study [18].
Figure 1. 
Histology of ACR of the intestinal allograft. The onset of ACR. Eosinophil infiltrates are observed in the 
ulcerated mucosa (left, 100×). Apoptotic bodies are observed in the crypt (indicated by arrows, middle, 200×; 
right, 100×, TUNEL-stained with 3,3’-diaminobenzidine).
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FasL and Fas, suggesting that the apoptosis relates to the FasL-Fas interactive reaction 
(Figure 2, lower panels). This result was first reported in our previous study [18].
3. Endoscopic examination and Peyer’s patch response
Endoscopically, elevation of the small intestinal mucosa may be recognized and 
biopsied when clinical rejection is suspected. Since this elevation is observed in 
patients who are not receiving oral nutrition, the change may not be the result of 
irritation from the lumen of the small intestine and more likely due to the reaction 
of the Peyer’s patches (PPs) to a load of patient cells on the graft mucosal immune 
system. In our cases, the biopsied Peyer’s patches were injured at the onset of ACR 
(Figures 3A and B). Therefore, PP is one of the targets of ACR or other types of 
rejection (Figure 3C). Notably, B cells increased in number in the disintegrated PPs 
(Figure 3). As described later, IL-5 was increased in the intestinal allograft [17], 
which may promote the transient B cell growth in PP.
Figure 3. 
Histology of a PP in an intestinal allograft. (A, B) A hyperplastic Peyer’s patch stained with CD79a antibody 
before ACR (A) and at the onset of ACR (B). (C) CD8 staining of PP after 42 h at the onset of rejection. Many 
CD8+ CTLs infiltrate in PP. CD79 and CD8 were visualized by DAB. The photo magnitude is 100×.
Figure 2. 
FasL immunostaining of the intestinal allograft. FasL-positive lymphocytes in the lamina propria (upper 
left, 200×) and Peyer’s patch (upper right, 400×) are shown. FasL-stained apoptotic bodies (lower left, 
400×). Apoptotic TCRVα24 stained cells (lower right, 400×). TCRVα24 and FasL were visualized with DAB 
(3,3’-diaminobenzidine).
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4. Cases at Kyoto University Hospital
Here we review cases of SBT at Kyoto University Hospital [17, 18, 21, 22]. SBT 
was performed owing to intestinal malrotation and Hirschsprung’s disease-related 
effects (Figure 4).
Jejunal or ileal grafts were monitored histologically. When fever, increased 
intestinal juice, abdominal pain, or C-reactive protein (CRP) elevation in peripheral 
blood (>0.5 mg/10−1 L) was observed, an endoscopic examination was performed. 
In particular, for the first 1 to 2 weeks after surgery, the examination was performed 
every other day, and a histological examination was also performed. Once the condi-
tion of the patient became stable, a histological examination was performed approxi-
mately once a week, and the state of the intestinal graft was monitored continuously 
for up to 2 months in the hospital. The patient received immunosuppressive therapy 
in combination with tacrolimus (trough concentration: 20 ng/mL) and methyl-
prednisolone (30 mg/kg/day, 1 to 3 times). In the biopsy examination, diagnosis by 
hematoxylin and eosin staining and findings specific to rejection within 6 h were 
confirmed by immunostaining of frozen sections. For histological diagnosis, we 
stained the apoptosis-related proteins such as FasL and surface antigens of B cells, 
T cells, and NK cells in each case. Steroid pulse therapy was conducted following 
Figure 4. 
Immunofluorescent staining of natural killer T cells in the intestinal allograft. Immunostaining of an intestinal 
allograft. Green signal, FITC and red signal, phycoerythrin [PE]. Nuclei are stained with DAPI (blue). Brown 
signal was visualized with DAB. (A) TCRVα24 (200×) and (B) TCRβ11 (200×). (C, D) TCRVα24 (green) 
and IL-4 (red) (IL-4 positive iNKT is indicated by an arrow). The observation magnification is 200× in both 
cases. (E, F) TCRVα24 (red) and TUNEL (green). (E) TUNEL+ (apoptotic) TCRVα24 + iNKT cells are 
observed at the onset of ACR (100×) and (F) 48 h after the onset of ACR (100×). Doubly stained cells were 
increased 48 h after the onset of ACR. (G) CD1d+ dendritic cells. CD1d and CD11c were stained green and 
red, respectively. (H) TCRVα24 stained iNKT cells (red) and CD1d stained dendritic cells (green). (I) FasL+ 
(green) TCRVα24+ (red) iNKT cells. The observation magnification is 400 x in (G)-(I).”
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detecting the immunological activation with the appearance of FasL-positive T/ 
NKT cells and apoptotic bodies in the lamina propria. The treatment substantially 
prevented the progression of the crypt apoptosis [17, 18, 21, 22].
5. Cytokine production in the intestinal allograft
5.1 NKT cells and cytokines
NKT cells are resident in the large bowel and increase in number in the colorectal 
cancer tissue [26]. The NKT cells have a limited T cell repertoire, and the restricted 
types are called invariant types of NKT (iNKT) cells. During the onset of intestinal 
rejection, the α chain 24 (TCRVα24) and β chain 11 (TCRVβ11) on iNKT cells are 
positively stained (Figure 4A and B) [17]. iNKT cells are mainly involved in innate 
immunity against glycolipids with the assistance of CD1d + dendritic cells [27]. 
Since iNKT cells are not identified in the small intestine of healthy donors before 
transplantation, this finding to be an indicator of ACR [17, 28].
Th1 cytokines, such as interferon-gamma (IFN-γ), generally act on the differen-
tiation of CTLs, which promote rejection, while Th2 cytokines may suppress ACR of 
SBT. TCRVα24 (+) invariant NKT (iNKT) cells are positive for interleukin 4 (IL-4) 
in allografts of the intestine during rejection (Figure 4C and D) [8]. The apoptosis 
of iNKT cells are observed at the onset of rejection (Figure 4E and F), indicating 
that a part of apoptotic cells in the lamina propria are iNKT cells (Figure 2,  
lower right). CD1d+ dendritic cells are detected during the rejection process at the 
same time that the rejection progressed (Figure 4G and H). The involvement of 
iNKT cells in the rejection reaction has been discussed previously, and there is also 
an experimental report regarding their involvement in tolerance [29, 30]. However, 
the involvement of iNKT cells in rejection has not yet become apparent [31]. 
Furthermore, the mechanism by which the expression of IL-4 is directly involved 
in mucosal immune regulation remains unclear. However, IL-4 may suppress the 
action of CTLs that cause rejection. On the other hand, iNKT cells expressed FasL, 
indicating that they are activated in ACR (Figure 4I).
In addition, increased IL-5 production is also observed at the onset of rejection. 
IL-5 promotes eosinophil differentiation and chemotaxis [32]. This increase in 
production may explain the large number of eosinophils infiltrating the mucosa at the 
time of rejection [17]. Conventional T cells and iNKT cells may secrete IL-5 [17]. The 
role of eosinophils in rejection has often been debated [33] and there is a discussion 
on whether eosinophils may be the target of rejection therapy [34]. An increase in the 
rejection of eosinophils has also been reported in the transplanted liver [35]. In the 
small intestine, the presence of the mucosal immune system may further complicate 
the graft’s immunological environment. Increased eosinophils, however, are histo-
logically detectable and may provide useful information for the diagnosis of rejec-
tion, even in small bowel transplant grafts [5]. As a result of an imbalance in mucosal 
immunity, excess production of IL-4 and IL-5 may damage the mucosal epithelium. 
The administration of immunosuppressive drugs acts on iNKT cells in addition to 
cytotoxic T cells. Therefore, the distribution of immunocompetent lymphocytes in 
the mucosa is disturbed, and the treatment protocol should be developed further.
6. Histological tolerance of the intestinal allograft
Finally, we reviewed a case of histological tolerance reported [25]. This case 
involves a transplant in a 4-year-old male patient who had short bowel syndrome 
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and previously underwent a living small bowel transplant from his mother who 
was in her twenties. The patient underwent a small intestinal biopsy 2–3 times per 
week for one month. Immunological analysis was performed using CD3, CD4, CD8, 
CD20, CD56, CD79a, perforin, granzyme B, FasL, Fas, and TUNEL staining. No 
severe rejection with an increase in FasL-positive T cells was detected. The maxi-
mum level of CRP, an inflammation marker, was 1.0 (mg/10−1 L) at POD67. In situ 
hybridization was performed using a Y-chromosome probe to evaluate rejection or 
tolerance for evaluation of the immunologic stability of the graft and chimeriza-
tion [36], which comprises multiplex staining with a CD3 fluorescent substance, 
for monitoring allografts. Figure 5 shows photographs of the graft 5 years after 
transplantation. A part of native T lymphocytes were replaced with Y-chromosome 
positive T lymphocytes from a male patient. This patient has been living for longer 
than ten years without any clinical symptoms, such as rejection, and is likely one of 
the first cases of operational tolerance.
7. Conclusion
Early diagnosis of rejection of the transplanted small intestine is essential to 
facilitate the initiation of therapy that interferes with rejection progression. In 
addition to crypt apoptosis, apoptotic bodies in the lamina propria is considered 
useful for diagnosis. Furthermore, iNKT cell infiltration was another characteristic 
finding. Since histologic features of ACR have been studied extensively. Of note in 
future diagnoses are the issues of humoral and chronic rejection.
Appendices and nomenclature
ACR acute cellular rejection
CMV cytomegalovirus
CRP C-reactive protein
CTL cytotoxic T lymphocyte
EBV Epstein–Barr virus
Figure 5. 
Combined in situ hybridization of lymphocytes with the Y-chromosome probe (red: PE) and CD3-lymphocytic 
immunohistochemistry (green: FITC). The photos show the double-stained T cells carrying the Y-chromosomal 
investigation, indicating the male-donor derived lymphocytes in the female-derived intestinal allograft. Left 
(100×) and right (400×). The nuclei were stained red, indicating Y-chromosome positivity.
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